Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Tumour Metabolism in Cisplatin Resistance
Lude Wang, Xiaoya Zhao, Jianfei Fu, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 68

Showing 26-50 of 68 citing articles:

The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics
Zhenrui Pan, H.T. Zhang, Svetlana Dokudovskaya
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10651-10651
Open Access | Times Cited: 9
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics
Tatiana J. Carneiro, Ana L. M. Batista de Carvalho, Martin Vojtek, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Histone acetylation: a key determinant of acquired cisplatin resistance in cancer
Abhiram Natu, Tripti Verma, Bharat Khade, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Cisplatin-Induced Metabolic Responses Measured with Raman Spectroscopy in Cancer Cells, Spheroids, and Canine-Derived Organoids
Siddhant Kothadiya, Gabriel Cutshaw, Saji Uthaman, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 38, pp. 50267-50281
Closed Access | Times Cited: 3
Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin
Avital Granit, Kumudesh Mishra, Dinorah Barasch, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 14
Antitumor Activity of Bioactive Compounds from Rapana venosa against Human Breast Cell Lines
Maria Petrova, Zlatina Vlahova, Maria Schröder, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 181-181
Open Access | Times Cited: 8
Elevated PAF1-RAD52 axis confers chemoresistance to human cancers
Sanchita Rauth, Koelina Ganguly, Pranita Atri, et al.
Cell Reports (2023) Vol. 42, Iss. 2, pp. 112043-112043
Open Access | Times Cited: 7
Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines
Marie‐Christin Barth, Norman Häfner, Ingo B. Runnebaum, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5718-5718
Open Access | Times Cited: 7
A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis
Philipp König, Roman Zhulenko, Eloy Suparman, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 1, pp. 57-69
Open Access | Times Cited: 7
Near-Infrared-Responsive Choline-Calix[4]arene-Gold Nanostructures for Potential Photothermal Cancer Treatment
Grazia M. L. Consoli, Giuseppe Forte, Ludovica Maugeri, et al.
ACS Applied Nano Materials (2022) Vol. 6, Iss. 1, pp. 358-369
Open Access | Times Cited: 11
A novel prognostic related lncRNA signature associated with amino acid metabolism in glioma
Qiang Lei, Bo Yuan, Kun Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Genome-wide CRISPR/Cas9 screening for drug resistance in tumors
Zhongyan Zhang, Hailiang Wang, Qian Yan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Organogold(III)-dithiocarbamate compounds and their coordination analogues as anti-tumor and anti-leishmanial metallodrugs
Ana Luiza de Andrade Querino, Alessandra Mara de Sousa, Sophie R. Thomas, et al.
Journal of Inorganic Biochemistry (2023) Vol. 247, pp. 112346-112346
Open Access | Times Cited: 5
Towards Personalized Management of Ovarian Cancer
Mashael Algethami, Sanat Kulkarni, Maaz Tahir Sadiq, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3469-3483
Open Access | Times Cited: 9
MiR-375 promotes cisplatin sensitivity of lung adenocarcinoma
Shuomeng Du, Han Qu, Ying Zhang, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154765-154765
Open Access | Times Cited: 5
Untargeted metabolomics analysis of omeprazole-enhanced chemosensitivity to cisplatin in mice with non-small cell lung cancer
Huan Gao, Yanqing Song, Jie Ma, et al.
Chemico-Biological Interactions (2022) Vol. 360, pp. 109933-109933
Closed Access | Times Cited: 8
Silencing the expression of lncRNA SNHG15 may be a novel therapeutic approach in human breast cancer through regulating miR-345-5p
Minshu Zhu, Haifei Xiang, Zheng Peng, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 21, pp. 1173-1173
Open Access | Times Cited: 8
Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy/lysosomal pathway
Alejandro Belmonte-Fernández, Joaquín Herrero‐Ruiz, María Galindo‐Moreno, et al.
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 488-499
Open Access | Times Cited: 8
Synthesis and comparative evaluation of the cytotoxic activity of cationic organometallic complexes of the type [Pt(η1-CH2-CH2-OR)(DMSO)(phen)]+ (R = Me, Et, Pr, Bu)
Erika Stefàno, Federica De Castro, Erik De Luca, et al.
Inorganica Chimica Acta (2022) Vol. 546, pp. 121321-121321
Closed Access | Times Cited: 8
Formulation and characterization of cisplatin-loaded hydroxyl functionalized single-walled carbon nanotubes for targeting gastric cancer stem cells
A. N. K. V. Sravani, Natarajan Chandrasekaran, John Thomas, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18798-e18798
Open Access | Times Cited: 4
<em>Siegesbeckia orientalis</em> Suppresses Growth and Migration through Apoptosis and Inhibition of Matrix Metalloproteinases Expression on Hepatoma in Mice
Tzu‐Hua Chen, Jer‐Yiing Houng, Tzu-Hsien Chang, et al.
(2024)
Open Access | Times Cited: 1
Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect
Julieta Afonso, Catarina Barbosa-Matos, Ricardo Silvestre, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1418-1418
Open Access | Times Cited: 1
High-throughput single-cell metabolites profiling reveals metabolic reprogramming confers cisplatin resistance in lung cancer
Chang-Yi Liu, Si-Yuan Pan, Xingyu Pan, et al.
Talanta (2024) Vol. 285, pp. 127355-127355
Closed Access | Times Cited: 1
Precise Carrier-Free Pt(IV)-Nanobombs for Apoptosis/Ferroptosis Synergistic Tumor Therapy: A New Effective Method to Obtain Good Chemotherapy and Low Toxicity
Xu Guo, Xin Liang, Jiale Liu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
Sergi Benavente
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 291-313
Open Access | Times Cited: 3

Scroll to top